Caicun Zhou

Camrelizumab Plus Apatinib in Extensive-Stage SCLC (PASSION): A Multicenter, Two-Stage, Phase 2 Trial

Yun Fan, Jun Zhao, Qiming Wang et al. · Journal of Thoracic Oncology · 2020 · 139 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

MHC class II expression in lung cancer

Yayi He, Leslie Rozeboom, Christopher J. Rivard et al. · Lung Cancer · 2017 · 122 citations

Life Sciences, Immunology, Oncology +14

MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines

Yongsheng Wang, Yinhua Wang, Hongping Xia et al. · Asian Pacific Journal of Cancer Prevention · 2012 · 114 citations · Full text

Medicine, Molecular Biology, Oncology +17

<p>OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer</p>

Juan Deng, Sha Zhao, Xiaoshen Zhang et al. · OncoTargets and Therapy · 2019 · 84 citations · Full text

Medicine, Immunology, Oncology +12

Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes

Shuyan Meng, Bo Su, Wěi Li et al. · Nanotechnology · 2010 · 61 citations

Pharmacy, Oncology, Pharmacology +17